SCHEMBL4692378

SCHEMBL4692378

O=C(O)N1Cc2c(cnn2CCSc2ccccc2)C(O)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.39
NPC1 O15118 7/20 0.39
SMN1; SMN2 Q16637 7/20 0.37
ALDH1A1 P00352 7/20 0.37
POLB P06746 1/20 0.37
THRB P10828 1/20 0.37
KDM4E B2RXH2 4/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
USP2 O75604 1/20 0.34
FKBP1A P62942 1/20 0.34
MAPT P10636 1/20 0.34
MTNR1A P48039 1/20 0.33
MTNR1B P49286 1/20 0.33
CASP3 P42574 1/20 0.33
SENP8 Q96LD8 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2B Q13224 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4692979 0.77 RAB9A (0.40) RAB9ANPC1SMN1; SMN2ALDH1A1POLB
SCHEMBL4692428 0.73 KEAP1 (0.44) NPC1SMN1; SMN2ALDH1A1POLBMAPT
SCHEMBL5258341 0.73 PLK1 (0.31)
SCHEMBL4146994 0.67 NPC1 (0.36) RAB9ANPC1SMN1; SMN2ALDH1A1THRB
SCHEMBL8816564 0.64 GRIN1 (0.44) GRIN1GRIN2B
SCHEMBL5251685 0.64 CYP1A2 (0.40) RAB9ANPC1SMN1; SMN2ALDH1A1POLB
SCHEMBL4281174 0.61 ALDH1A1 (0.46) RAB9ANPC1SMN1; SMN2ALDH1A1POLB
SCHEMBL5254840 0.60 RAB9A (0.39) RAB9ANPC1SMN1; SMN2ALDH1A1POLB
SCHEMBL5255225 0.60 DPP8 (0.35) KDM4E
SCHEMBL5257722 0.58 SMN1; SMN2 (0.51) RAB9ANPC1SMN1; SMN2ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1569935-B1 HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREOF AND USE OF SAME AS MEDICAMENTS, SUCH AS ANTI-BACTERIAL MEDICAMENTS AND BETA-LACTAMASE INHIBITORS NOVEXEL (FR) 2008-08-20 EP disclosed
EP-1798231-A2 Intermediate products for the preparation of antibacterial compounds NOVEXEL (FR) 2007-06-20 EP disclosed
EP-1399444-B1 NOVEL HETEROCYCLIC COMPOUNDS, METHOD FOR PREPARING SAME AND USE THEREOF AS MEDICINES, IN PARTICULAR AS ANTI-BACTERIAL AGENTS NOVEXEL (FR) 2007-04-11 EP disclosed